VANDA PHARMACEUTICALS INC. Earnings Per Share (Basic)
VANDA PHARMACEUTICALS INC. (VNDA) reported Earnings Per Share (Basic) of -$1.04 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- VANDA PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.04.
- VANDA PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.82.
- VANDA PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2025-12-31 was -$2.39.
- VANDA PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.38.
- VANDA PHARMACEUTICALS INC. earnings per share, basic for fiscal 2025 was -$3.74.
- VANDA PHARMACEUTICALS INC. earnings per share, basic for fiscal 2024 was -$0.33, a 925.00% decline from fiscal 2023.
- VANDA PHARMACEUTICALS INC. earnings per share, basic for fiscal 2023 was $0.04, a 63.64% decline from fiscal 2022.
- VANDA PHARMACEUTICALS INC. earnings per share, basic for fiscal 2022 was $0.11, a 81.67% decline from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.04 10-Q · filed 2026-08-06 | -$1.86 10-Q · filed 2026-08-06 | -$4.23 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$4.62 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2026-03-31 | -$0.82 10-Q · filed 2026-05-07 | -$3.20 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.59 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$4.05 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2025-12-31 | -$2.39 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$2.77 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$3.23 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.74 10-K · filed 2026-02-12 | |
| 2025-09-30 | -$0.38 10-Q · filed 2025-10-30 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.35 10-Q · filed 2025-10-30 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2025-06-30 | -$0.46 10-Q · filed 2026-08-06 | -$0.96 10-Q · filed 2026-08-06 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2025-03-31 | -$0.50 10-Q · filed 2026-05-07 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2024-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.33 10-K · filed 2026-02-12 | |
| 2024-09-30 | -$0.09 10-Q · filed 2025-10-30 | -$0.17 derived: net income ÷ weighted average shares · filed 2025-10-30 | -$0.24 10-Q · filed 2025-10-30 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-04-23 | |
| 2024-06-30 | -$0.08 10-Q · filed 2025-07-31 | -$0.15 10-Q · filed 2025-07-31 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-04-23 | |
| 2024-03-31 | -$0.07 10-Q · filed 2025-05-08 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-04-23 | |
| 2023-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.04 10-K · filed 2026-02-12 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.03 derived: net income ÷ weighted average shares · filed 2024-11-07 | $0.09 10-Q · filed 2024-11-07 | $0.21 derived: net income ÷ weighted average shares · filed 2026-04-23 | |
| 2023-06-30 | $0.03 10-Q · filed 2024-08-01 | $0.08 10-Q · filed 2024-08-01 | $0.20 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.26 derived: net income ÷ weighted average shares · filed 2026-04-23 | |
| 2023-03-31 | $0.06 10-Q · filed 2024-05-09 | $0.18 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.24 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.28 derived: net income ÷ weighted average shares · filed 2026-04-23 | |
| 2022-12-31 | $0.12 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.18 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.22 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.11 10-K · filed 2025-02-14 | |
| 2022-09-30 | $0.06 10-Q · filed 2023-11-09 | $0.10 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.01 10-Q · filed 2023-11-09 | $0.12 derived: net income ÷ weighted average shares · filed 2026-04-23 | |
| 2022-06-30 | $0.05 10-Q · filed 2023-07-28 | -$0.07 10-Q · filed 2023-07-28 | $0.06 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.20 derived: net income ÷ weighted average shares · filed 2026-04-23 | |
| 2022-03-31 | -$0.11 10-Q · filed 2023-05-03 | $0.01 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.15 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.32 derived: net income ÷ weighted average shares · filed 2026-04-23 | |
| 2021-12-31 | $0.13 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.27 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.44 derived: net income ÷ weighted average shares · filed 2026-04-23 | $0.60 10-K · filed 2024-02-08 | |
| 2021-09-30 | $0.14 10-Q · filed 2022-11-03 | $0.31 derived: net income ÷ weighted average shares · filed 2022-11-03 | $0.47 10-Q · filed 2022-11-03 | $0.62 derived: net income ÷ weighted average shares · filed 2023-02-09 | |
| 2021-06-30 | $0.17 10-Q · filed 2022-08-04 | $0.33 10-Q · filed 2022-08-04 | $0.48 derived: net income ÷ weighted average shares · filed 2023-02-09 | $0.59 derived: net income ÷ weighted average shares · filed 2023-02-09 | |
| 2021-03-31 | $0.16 10-Q · filed 2022-05-06 | $0.31 derived: net income ÷ weighted average shares · filed 2023-02-09 | $0.42 derived: net income ÷ weighted average shares · filed 2023-02-09 | $0.58 derived: net income ÷ weighted average shares · filed 2023-02-09 | |
| 2020-12-31 | $0.15 10-K · filed 2021-02-11 | $0.26 derived: net income ÷ weighted average shares · filed 2023-02-09 | $0.42 derived: net income ÷ weighted average shares · filed 2023-02-09 | $0.43 10-K · filed 2023-02-09 | |
| 2020-09-30 | $0.11 10-Q · filed 2021-11-04 | $0.27 derived: net income ÷ weighted average shares · filed 2021-11-04 | $0.28 10-Q · filed 2021-11-04 | $0.36 derived: net income ÷ weighted average shares · filed 2022-02-24 | |
| 2020-06-30 | $0.16 10-Q · filed 2021-07-29 | $0.17 10-Q · filed 2021-07-29 | $0.25 derived: net income ÷ weighted average shares · filed 2022-02-24 | $2.12 derived: net income ÷ weighted average shares · filed 2022-02-24 | |
| 2020-03-31 | $0.01 10-Q · filed 2021-05-06 | $0.09 derived: net income ÷ weighted average shares · filed 2022-02-24 | $1.96 derived: net income ÷ weighted average shares · filed 2022-02-24 | $2.18 derived: net income ÷ weighted average shares · filed 2022-02-24 | |
| 2019-12-31 | $0.08 10-K · filed 2021-02-11 | $1.96 derived: net income ÷ weighted average shares · filed 2022-02-24 | $2.18 derived: net income ÷ weighted average shares · filed 2022-02-24 | $2.17 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.88 10-K · filed 2021-02-11 | $2.10 derived: net income ÷ weighted average shares · filed 2021-02-11 | $2.10 10-Q · filed 2020-10-29 | $2.30 derived: net income ÷ weighted average shares · filed 2021-02-11 | |
| 2019-06-30 | $0.22 10-K · filed 2021-02-11 | $0.21 10-Q · filed 2020-08-06 | $0.40 derived: net income ÷ weighted average shares · filed 2021-02-11 | $0.54 derived: net income ÷ weighted average shares · filed 2021-02-11 | |
| 2019-03-31 | -$0.01 10-K · filed 2021-02-11 | $0.19 derived: net income ÷ weighted average shares · filed 2021-02-11 | $0.32 derived: net income ÷ weighted average shares · filed 2021-02-11 | $0.41 derived: net income ÷ weighted average shares · filed 2021-02-11 | |
| 2018-12-31 | $0.20 10-K · filed 2020-02-26 | $0.33 derived: net income ÷ weighted average shares · filed 2021-02-11 | $0.42 derived: net income ÷ weighted average shares · filed 2021-02-11 | $0.50 10-K · filed 2021-02-11 | |
| 2018-09-30 | $0.14 10-K · filed 2020-02-26 | $0.23 derived: net income ÷ weighted average shares · filed 2020-02-26 | $0.30 10-Q · filed 2019-11-07 | $0.27 derived: net income ÷ weighted average shares · filed 2020-02-26 | |
| 2018-06-30 | $0.09 10-K · filed 2020-02-26 | $0.16 10-Q · filed 2019-08-01 | $0.12 derived: net income ÷ weighted average shares · filed 2020-02-26 | $0.03 derived: net income ÷ weighted average shares · filed 2020-02-26 | |
| 2018-03-31 | $0.07 10-K · filed 2020-02-26 | $0.03 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$0.07 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$0.11 derived: net income ÷ weighted average shares · filed 2020-02-26 | |
| 2017-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$0.14 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-02-26 | -$0.35 10-K · filed 2020-02-26 | |
| 2017-09-30 | -$0.10 10-Q · filed 2018-11-07 | -$0.14 derived: net income ÷ weighted average shares · filed 2019-02-19 | -$0.31 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$0.03 10-Q · filed 2018-08-02 | -$0.21 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | -$0.17 10-Q · filed 2018-05-02 | ||||
| 2016-12-31 | -$0.41 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | -$0.94 10-K · filed 2018-02-15 | ||||
| 2014-12-31 | $1.85 10-K · filed 2016-02-12 | $0.58 10-K · filed 2017-02-17 | |||
| 2014-09-30 | -$0.04 10-K · filed 2016-02-12 | ||||
| 2014-06-30 | -$0.64 10-K · filed 2016-02-12 | ||||
| 2014-03-31 | -$0.79 10-K · filed 2016-02-12 | ||||
| 2013-12-31 | -$0.23 10-K · filed 2014-02-25 | -$0.41 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$0.53 derived: net income ÷ weighted average shares · filed 2016-02-12 | -$0.69 10-K · filed 2016-02-12 | -$0.67 10-K · filed 2014-02-25 |
| 2013-09-30 | -$0.17 10-K · filed 2014-02-25 | -$0.29 derived: net income ÷ weighted average shares · filed 2015-03-13 | -$0.43 10-Q · filed 2013-11-08 | -$0.68 derived: net income ÷ weighted average shares · filed 2015-03-13 | |
| 2013-06-30 | -$0.11 10-K · filed 2014-02-25 | -$0.26 10-Q · filed 2013-07-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2015-03-13 | -$0.69 derived: net income ÷ weighted average shares · filed 2015-03-13 | |
| 2013-03-31 | -$0.15 10-K · filed 2014-02-25 | -$0.38 derived: net income ÷ weighted average shares · filed 2015-03-13 | -$0.57 derived: net income ÷ weighted average shares · filed 2015-03-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2015-03-13 | |
| 2012-12-31 | -$0.23 10-K · filed 2014-02-25 | -$0.41 derived: net income ÷ weighted average shares · filed 2015-03-13 | -$0.70 derived: net income ÷ weighted average shares · filed 2015-03-13 | -$1.01 10-K · filed 2015-03-13 | -$0.98 10-K · filed 2013-02-26 |
| 2012-09-30 | -$0.19 10-K · filed 2014-02-25 | -$0.47 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$0.75 10-Q · filed 2013-11-08 | -$0.95 derived: net income ÷ weighted average shares · filed 2014-02-25 | |
| 2012-06-30 | -$0.28 10-K · filed 2014-02-25 | -$0.57 10-Q · filed 2013-07-31 | -$0.76 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$0.87 derived: net income ÷ weighted average shares · filed 2014-02-25 | |
| 2012-03-31 | -$0.28 10-K · filed 2014-02-25 | -$0.48 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$0.59 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$0.64 derived: net income ÷ weighted average shares · filed 2014-02-25 | |
| 2011-12-31 | -$0.20 10-K · filed 2013-02-26 | -$0.31 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$0.35 derived: net income ÷ weighted average shares · filed 2014-02-25 | -$0.35 10-K · filed 2014-02-25 | |
| 2011-09-30 | -$0.11 10-K · filed 2013-02-26 | -$0.16 derived: net income ÷ weighted average shares · filed 2013-02-26 | -$0.15 10-Q · filed 2012-11-08 | -$0.07 derived: net income ÷ weighted average shares · filed 2013-02-26 | |
| 2011-06-30 | -$0.05 10-K · filed 2013-02-26 | -$0.04 10-Q · filed 2012-08-03 | $0.04 derived: net income ÷ weighted average shares · filed 2013-02-26 | $0.15 derived: net income ÷ weighted average shares · filed 2013-02-26 | |
| 2011-03-31 | $0.00 10-Q · filed 2012-05-09 | $0.08 derived: net income ÷ weighted average shares · filed 2013-02-26 | $0.20 derived: net income ÷ weighted average shares · filed 2013-02-26 | $0.24 derived: net income ÷ weighted average shares · filed 2013-02-26 | |
| 2010-12-31 | $0.08 derived: net income ÷ weighted average shares · filed 2013-02-26 | $0.19 derived: net income ÷ weighted average shares · filed 2013-02-26 | $0.24 derived: net income ÷ weighted average shares · filed 2013-02-26 | $0.26 10-K · filed 2013-02-26 | |
| 2010-09-30 | $0.11 10-Q · filed 2011-11-07 | $0.16 derived: net income ÷ weighted average shares · filed 2011-11-07 | $0.18 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $0.05 10-Q · filed 2011-08-05 | $0.07 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | -$1.33 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |